References
[1] RUPPRECHT, CHARLES E, GIBBONS, et al. Prophylaxis against Rabies [J]. New England Journal of Medicine, 2005, 351(25):2626-35.
[2] DANIEL, G., HANKINS, et al. Overview, Prevention, and Treatment of Rabies [J]. Mayo Clinic Proceedings, 2004, 29(10):1182-95.
[3] MADHUSUDANA S N, SUBHA S, THANKAPPAN U, et al. Evaluation of a direct rapid immunohistochemical test (dRIT) for rapid diagnosis of rabies in animals and humans [J]. Virologica Sinica, 2012, 27(005): 299-302.
[4] ALBERTINI A, RUIGROK R, BLONDEL D. Chapter 1 - Rabies Virus Transcription and Replication [M]. Advances in Virus Research, 2011, 79:1-22.
[5] ZHU S, GUO C. Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential [J]. Viruses, 2016, 8(11): 279.
[6] ANILIONIS A, WUNNER W H, CURTIS P J. Structure of the glycoprotein gene in rabies virus [J]. Nature, 1981, 294(5838):275-8.
[7] FISHER, CHRISTINE, R., et al. The spread and evolution of rabies virus: conquering new frontiers [J]. Nature Reviews Microbiology, 2018, 16(4):241-255.
[8] FOOKS A R, CLIQUET F, FINKE S, et al. Rabies [J]. Nature Reviews Disease Primers, 2017, 3(1): 17091.
[9] YANG D K, YOUNG-NAM P, HONG G S, et al. Molecular characterization of Korean rabies virus isolates [J]. Journal of Veterinary Science, 2011, 12(1): 57-63.
[10] BRACCI L, ANTONI G, CUSI M G, et al. Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor [J]. Molecular Immunology, 1988, 25(9): 881-8.
[11] Jonathan Covault, Joshua R. Sanes. Distribution of N-CAM in synaptic and extrasynaptic portions of developing and adult skeletal muscle [J]. J Cell Biol, 1986, 102(3):716-30.
[12] DOUGHERTY K D, MILNER T A. p75NTR immunoreactivity in the rat dentate gyrus is mostly within presynaptic profiles but is also found in some astrocytic and postsynaptic profiles [J]. Journal of Comparative Neurology, 1999, 28;407(1):77-91.
[13] HENRY W, PAKAMATZ K, THIRAVAT H, et al. Postexposure treatment of rabies infection: can it be done without immunoglobulin? [J]. Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America, 2002, (4): 477.
[14] BERNHARD, DIETZSCHOLD, MILOSZ, et al. New approaches to the prevention and eradication of rabies [J]. Expert Review of Vaccines, 2003, 2(3):399-406.
[15] RUPPRECHT C E, BARRETT J, BRIGGS D, et al. Can rabies be eradicated? [J]. Developments in Biologicals, 2008, 131: 95-121.
[16] GACOUIN A, BOURHY H, RENAUD J C, et al. Human Rabies Despite Postexposure Vaccination [J]. Eur J Clin Microbiol Infect Dis, 1999, 18(3): 233-5.
[17] WILDE H, CHOOMKASIEN P, HEMACHUDHA T, et al. Failure of rabies postexposure treatment in Thailand [J]. Vaccine, 1989, 7(1): 49-52.
[18] Failure of postexposure treatment of rabies in children [J]. Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America, 1996, 22(2):228-32.
[19] CHI X, LI J, LIU W, et al. Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine [J]. American Society for Microbiology, 2015, 22(5):553-60.
[20] KUMAR P, WU H, MCBRIDE J L, et al. Transvascular delivery of small interfering RNA to the central nervous system [J]. Nature, 2007, 448(7149): 39-43.
[21] WUNNER W H. Is the acetylcholine receptor a rabies-virus receptor? [J]. Trends in Neurosciences, 1982, 56(4):315-22.
[22] LEE C, HWANG H S, LEE S, et al. Rabies Virus‐Inspired Silica‐Coated Gold Nanorods as a Photothermal Therapeutic Platform for Treating Brain Tumors [J]. Advanced Materials, 2017, 29(13): 1605563.
[23] ZHANG R F Y, CHENG M, MA W, ZHENG N, WANG Y, WU Z. sEVsRVG selectively delivers antiviral siRNA to fetus brain, inhibits ZIKV infection and mitigates ZIKV-induced microcephaly in mouse model [M]. 2022.
[24] Y Gaudin, R W Ruigrok, M Knossow, et al. Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion [J]. J Virol, 1993, 67(3):1365-72.
[25] GAUDIN Y, TUFFEREAU C, DURRER P, et al. Biological function of the low-pH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusion-inactive state-like conformation [J]. Journal of Virology, 1995, 69(9): 5528-34.
[26] ALBERTINI A, BRESSANELLI S, LEPAULT J, et al. Structure and Working of Viral Fusion Machinery [J]. 2011, 68: 49-80.
[27] Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody [J]. The Journal of Infectious Diseases, 2014, 210(2):200-8.
[28] DE BENEDICTIS P, MINOLA A, ROTA NODARI E, et al. Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis [J]. EMBO Molecular Medicine, 2016, 8(4): 407-21.
[29] M LLER T, DIETZSCHOLD B, ERTL H, et al. Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans [J]. Plos Negl Trop Dis, 2009, 3(11): e542.
[30] TSEKOA T L, LOTTER-STARK T, BUTHELEZI S, et al. Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3 [J]. Plos One, 2016, 11(7): e0159313.
[31] BOURHY H, KISSI B, AUDRY L, et al. Ecology and evolution of rabies virus in Europe [J]. Journal of General Virology, 1999, 80 ( Pt 10):2545-2557.
[32] CARNIELI P, BRAND?O P E, CARRIERI M L, et al. Molecular epidemiology of rabies virus strains isolated from wild canids in Northeastern Brazil [J]. Virus Research, 2006, 120(1-2): 113-20.
[33] KUZMIN I V, ORCIARI L A, ARAI Y T, et al. Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences [J]. Virus Research, 2003, 97(2): 65-79.
[34] SCHAEFER R, BATISTA H, FRANCO A C, et al. Studies on antigenic and genomic properties of Brazilian rabies virus isolates [J]. Veterinary Microbiology, 2005, 107(3-4): 161-70.
[35] CAI M, LIU H, JIANG F, et al. Analysis of the evolution, infectivity and antigenicity of circulating rabies virus strains [J]. Emerging Microbes & Infections, 2022, 11(1): 1474-87.
[36] YANG F, LIN S, YE F, et al. Structural Analysis of Rabies Virus Glycoprotein Reveals pH-Dependent Conformational Changes and Interactions with a Neutralizing Antibody [J]. Cell Host & Microbe, 2020, 27(3):441-453.e7.
[37] OTWINOWSKI Z, MINOR W. [20] Processing of X-ray diffraction data collected in oscillation mode - ScienceDirect [J]. Methods in Enzymology, 1997, 276: 307-26.
[38] READ R J. Pushing the boundaries of molecular replacement with maximum likelihood. Erratum [J]. Acta Crystallographica Section D Biological Crystallography, 2001, 57(Pt 10):1373-82.
[39] EMSLEY P, COWTAN K. Coot: model-building tools for molecular graphics [J]. Acta Crystallographica Section D: Biological Crystallography, 2001, 57(Pt 10):1373-82.
[40] ADAMS P D, AFONINE P V, BUNK CZI G, et al. PHENIX: a comprehensive Python‐based system for macromolecular structure solution [J]. Acta Crystallogr D Biol Crystallogr, 2010 Feb;66(Pt 2):213-21.
[41] WILLIAMS C J, HEADD J J, MORIARTY N W, et al. MolProbity: More and better reference data for improved all-atom structure validation [J]. Protein Science, 2018, 27(1): 293-315.